Feed SUNPHARMA.NS
SU

Sun Pharmaceutical Industries Limited

SUNPHARMA.NS · NSE

₹1,795.00 +0.86% (+₹15.30)
1M -6.08%
Market Cap ₹4.27T
P/E Ratio 35.26x
Div. Yield 0.28%
ROE 14.96%

Bulios Fair Price

₹1,518

15.4% downside

Current Price

₹1,795

Undervalued Fair Value Overvalued

According to Bulios Fair Price, SUNPHARMA.NS is currently overvalued relative to its market price. How does it work?

Unlock fair price

Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?

Analysis

An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.

Piotroski F-Score Moderate
4/9
Valuation
12 /100
Expensive
PEG 7.38x
P/E 35.26x
P/B 5.08x
Growth
77 /100
Growing
FCF growth 47.61%
EPS growth 10.61%
Book val. growth 14.28%
Profitability
77 /100
Strong
Op. margin 22.93%
Gross margin 55.75%
FCF margin 3.99%
Quality
70 /100
Excellent
ROE 14.96%
Asset turnover N/A
ROIC N/A
Debt
100 /100
Low
Net debt/EBITDA 0.00x
Debt/Equity 0.00x
Int. coverage 43.22x
Stability
75 /100
Stable
EPS volatility 5.12%
Beta 0.08x
Profitable years 6

Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more

Ask StockBot about SUNPHARMA.NS
Online

Sector

Healthcare

Industry

Drug Manufacturers - Specialty & Generic

CEO

Kirti Ganorkar

Employees

47,000

Headquarters

Mumbai

Upcoming events

03 NOV

Earnings

Upcoming earnings report

28d

We use essential cookies to run the website and optional analytics cookies to measure usage. See our Privacy Policy.